Re: Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: A Phase 1b Trial. Guo Y, Zhang W, Zhang J, Mao S, et al. Eur Urol 2025 Jul 28:S0302-2838(25)00406-3. doi: 10.1016/j.eururo.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Guo Y, Zhang W, Zhang J, Mao S, et al. Re: Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: A Phase 1b Trial. Eur Urol 2025 Jul 28:S0302-2838(25)00406-3. doi: 10.1016/j.eururo.2025.
PMID: 40731192